Abstract

This observational study at our center followed children with Retinopathy of Prematurity (ROP) over 24 months, to assess the prevalence and progression of refractive errors and squint, as well as the impact of ROP severity and treatment on these outcomes.Patient information, including birth history, oxygen therapy, NICU admission, and treatment records, was collected. Visual acuity, refraction, and cycloplegic refraction were done. Data was analysed using STATA 14.1 software.Myopia prevalence increased from 35.6% at 6 months to 41.8% at 24 months, with myopia becoming more severe .The incidence of myopia in the groups were Bevacizumab (18.8%)Observation (24.5%)Laser (46.35%)Bevacizumab + Laser (68.8%)Six children had squint.To conclude Myopia in ROP infants worsens with time.Severe ROP and laser treatment were associated with higher myopia rates.The Inj. Bevacizumab alone group exhibited better refractive outcomes.

Full Text